Healthcare costs and energy increasingly focus on the management of progressive diseases. In pivotal disease categories such as oncology, diabetes, auto-immune disease, or respiratory medicine, marketers need to position their products for treatment of specific patients at different points in therapy in combination with other agents.
Dynamic Practice Simulation® Line of Therapy studies allow you to trace the path of treatment for a specific patient from initial disease through multiple lines of therapy. Each patient moves from one line of therapy to the next as different treatments fail to stop the progression of disease. The research design allows you to control basic characteristics and then to explore different ways disease can progress. Therapies can succeed in slowing disease or not. Patients can experience safety issues or co-morbidities frequently associated with therapies. Through this entire process, RG+A can utilize our array of patient simulation tools to depict the situation present complex treatment options, and analyze the results.
Clients use Line of Therapy research for forecasting, positioning, and product development.